Widzowski D V, Cory-Slechta D A
Department of Environmental Medicine, University of Rochester School of Medicine and Dentistry, New York.
J Pharmacol Exp Ther. 1993 Aug;266(2):526-34.
This study examined the hypothesis that, if the stimulus properties of the D2 agonist quinpirole (QUIN) were mediated by autoreceptors, then pharmacological treatments engendering a decline in dopamine (DA) release and consequent decrease in postsynaptic DA receptor stimulation should result in QUIN-appropriate responding; those that activate postsynaptic receptors should result in saline-appropriate responding. In rats trained to discriminate 0.05 mg/kg of QUIN from saline using standard operant drug discrimination procedures, QUIN (up to the training dose), two other putative D2 autoreceptor agonists (low-dose apomorphine and N-propylnorapomorphine), the DA depeleter alpha-methyl-p-tyrosine (AMPT) and the D1 antagonist SCH 23390 all produced primarily QUIN-lever responding. Moreover, coadministration of alpha-methyl-p-tyrosine with QUIN potentiated QUIN-stimulus properties. Higher doses of apomorphine, known to stimulate postsynaptic D1 and D2 receptors and pretreatment with the D2 antagonist haloperidol decreased QUIN-lever responding. Neither the D1 agonist SKF38393, the indirect D1/D2 agonist d-amphetamine, the D2 antagonist haloperidol or coadministration of SCH 23390 and d-amphetamine substituted for QUIN. Coadministration of either SKF 38393 or d-amphetamine with QUIN decreased levels of QUIN responding. Taken together, the data are consistent with the contention that the stimulus properties of 0.05 mg/kg of QUIN are primarily mediated by D2-type presynaptic autoreceptors and that these stimulus properties involve a decline in DA release and consequent decreased postsynaptic stimulation.(ABSTRACT TRUNCATED AT 250 WORDS)
如果D2激动剂喹吡罗(QUIN)的刺激特性是由自身受体介导的,那么导致多巴胺(DA)释放减少以及突触后DA受体刺激随之减少的药物治疗应会产生与QUIN相应的反应;而那些激活突触后受体的治疗应会产生与生理盐水相应的反应。在使用标准操作性药物辨别程序训练大鼠区分0.05 mg/kg喹吡罗和生理盐水的实验中,喹吡罗(直至训练剂量)、另外两种假定的D2自身受体激动剂(低剂量阿扑吗啡和N-丙基去甲阿扑吗啡)、DA耗竭剂α-甲基-p-酪氨酸(AMPT)以及D1拮抗剂SCH 23390均主要产生与喹吡罗相关的杠杆反应。此外,α-甲基-p-酪氨酸与喹吡罗共同给药增强了喹吡罗的刺激特性。已知能刺激突触后D1和D2受体的较高剂量阿扑吗啡以及用D2拮抗剂氟哌啶醇预处理可减少与喹吡罗相关的杠杆反应。D1激动剂SKF38393、间接D1/D2激动剂d-苯丙胺、D2拮抗剂氟哌啶醇,或SCH 23390与d-苯丙胺共同给药均不能替代喹吡罗。SKF 38393或d-苯丙胺与喹吡罗共同给药降低了喹吡罗反应水平。综上所述,这些数据支持以下观点:0.05 mg/kg喹吡罗的刺激特性主要由D2型突触前自身受体介导,且这些刺激特性涉及DA释放减少以及随之而来的突触后刺激减少。(摘要截短于250字)